Heteromerization of Endogenous Mu and Delta Opioid Receptors Induces Ligand-Selective Co-Targeting to Lysosomes
暂无分享,去创建一个
[1] Shaoqiu He,et al. Activation of µ-δ opioid receptor heteromers inhibits neuropathic pain behavior in rodents. , 2019, Pain.
[2] P. Veinante,et al. Morphine-dependent and abstinent mice are characterized by a broader distribution of the neurons co-expressing mu and delta opioid receptors , 2019, Neuropharmacology.
[3] M. Barrot,et al. Peripheral delta opioid receptors mediate duloxetine antiallodynic effect in a mouse model of neuropathic pain , 2018, The European journal of neuroscience.
[4] A. Basbaum,et al. Functional Divergence of Delta and Mu Opioid Receptor Organization in CNS Pain Circuits , 2018, Neuron.
[5] P. Dallaire,et al. Analyzing biased responses of GPCR ligands. , 2017, Current opinion in pharmacology.
[6] G. Sanger,et al. Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug design , 2016, Scientific Reports.
[7] P. Sexton,et al. Systematic analysis of factors influencing observations of biased agonism at the mu-opioid receptor. , 2016, Biochemical pharmacology.
[8] J. Vonesch,et al. Impact of chronic morphine on delta opioid receptor-expressing neurons in the mouse hippocampus , 2016, Neuroscience.
[9] D. Filliol,et al. A Novel Anxiogenic Role for the Delta Opioid Receptor Expressed in GABAergic Forebrain Neurons , 2015, Biological Psychiatry.
[10] D. Massotte,et al. Fluorescent knock-in mice to decipher the physiopathological role of G protein-coupled receptors , 2015, Front. Pharmacol..
[11] L. Gendron,et al. Recent advances on the δ opioid receptor: from trafficking to function , 2015, British journal of pharmacology.
[12] L. Devi,et al. Heteromers of μ‐δ opioid receptors: new pharmacology and novel therapeutic possibilities , 2015, British journal of pharmacology.
[13] L. Devi,et al. Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR Review 10 , 2014, British journal of pharmacology.
[14] M. Olmstead,et al. Prolonged morphine treatment alters δ opioid receptor post-internalization trafficking , 2014, British journal of pharmacology.
[15] L. Trudeau,et al. Ligand- and cell-dependent determinants of internalization and cAMP modulation by delta opioid receptor (DOR) agonists , 2014, Cellular and Molecular Life Sciences.
[16] P. Veinante,et al. A mu–delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks , 2014, Brain Structure and Function.
[17] K. Befort,et al. 15 years of genetic approaches in vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuse , 2014, Neuropharmacology.
[18] B. Balleine,et al. Learning-Related Translocation of δ-Opioid Receptors on Ventral Striatal Cholinergic Interneurons Mediates Choice between Goal-Directed Actions , 2013, The Journal of Neuroscience.
[19] L. Devi,et al. Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity , 2013, Proceedings of the National Academy of Sciences.
[20] J. Vonesch,et al. In Vivo Visualization of Delta Opioid Receptors upon Physiological Activation Uncovers a Distinct Internalization Profile , 2012, The Journal of Neuroscience.
[21] Ying Xia,et al. Current research on opioid receptor function. , 2012, Current drug targets.
[22] J. Whistler,et al. Heteromerization of the μ- and δ-Opioid Receptors Produces Ligand-Biased Antagonism and Alters μ-Receptor Trafficking , 2011, Journal of Pharmacology and Experimental Therapeutics.
[23] Shaoqiu He,et al. Facilitation of μ-Opioid Receptor Activity by Preventing δ-Opioid Receptor-Mediated Codegradation , 2011, Neuron.
[24] G. Balboni,et al. Agonists at the δ‐opioid receptor modify the binding of µ‐receptor agonists to the µ–δ receptor hetero‐oligomer , 2010, British journal of pharmacology.
[25] J. Traynor,et al. G Protein independent phosphorylation and internalization of the δ‐opioid receptor , 2009, Journal of neurochemistry.
[26] D. Filliol,et al. In Vivo Delta Opioid Receptor Internalization Controls Behavioral Effects of Agonists , 2009, PloS one.
[27] B. O'dowd,et al. Trafficking of preassembled opioid μ-δ heterooligomer-Gz signaling complexes to the plasma membrane: Coregulation by agonists , 2007 .
[28] L. Devi,et al. Receptor heterodimerization leads to a switch in signaling: β‐arrestin2‐mediated ERK activation by μ‐δ opioid receptor heterodimers , 2007 .
[29] Michel Bouvier,et al. International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the Recognition and Nomenclature of G Protein-Coupled Receptor Heteromultimers , 2007, Pharmacological Reviews.
[30] A. Basbaum,et al. Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[31] J. Burbach,et al. Receptor‐selective changes in µ‐, δ‐ and κ‐opioid receptors after chronic naltrexone treatment in mice , 2003, The European journal of neuroscience.
[32] Jean-Christophe Olivo-Marin,et al. Extraction of spots in biological images using multiscale products , 2002, Pattern Recognit..
[33] M. von Zastrow,et al. Modulation of Postendocytic Sorting of G Protein-Coupled Receptors , 2002, Science.
[34] D. Filliol,et al. Quantitative autoradiographic mapping of opioid receptors in the brain of δ-opioid receptor gene knockout mice , 2002, Brain Research.
[35] C. Gaveriaux-Ruff,et al. Opioid receptor genes inactivated in mice: the highlights , 2002, Neuropeptides.
[36] A. Basbaum,et al. Postsynaptic Signaling via the μ-Opioid Receptor: Responses of Dorsal Horn Neurons to Exogenous Opioids and Noxious Stimulation , 2000, The Journal of Neuroscience.
[37] L. Devi,et al. Heterodimerization of mu and delta opioid receptors: A role in opiate synergy. , 2000, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[38] H. Loh,et al. Deltorphin II-induced Rapid Desensitization of δ-Opioid Receptor Requires Both Phosphorylation and Internalization of the Receptor* , 2000, The Journal of Biological Chemistry.
[39] S. Salvadori,et al. Further Studies on the Dmt-Tic Pharmacophore: Hydrophobic Substituents at the C-Terminus Endow δ Antagonists To Manifest μ Agonism or μ Antagonism , 1999 .
[40] Lakshmi A. Devi,et al. G-protein-coupled receptor heterodimerization modulates receptor function , 1999, Nature.
[41] D. Massotte,et al. Double Fluorescent Knock-In Mice to Investigate Endogenous Mu-Delta Opioid Heteromer Subcellular Distribution , 2018 .
[42] B. O'dowd,et al. Trafficking of preassembled opioid mu-delta heterooligomer-Gz signaling complexes to the plasma membrane: coregulation by agonists. , 2007, Biochemistry.
[43] L. Devi,et al. Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers. , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[44] S. Salvadori,et al. Further studies on the Dmt-Tic pharmacophore: hydrophobic substituents at the C-terminus endow delta antagonists to manifest mu agonism or mu antagonism. , 1999, Journal of Medicinal Chemistry.
[45] H. Matthes,et al. Quantitative autoradiographic mapping of mu-, delta- and kappa-opioid receptors in knockout mice lacking the mu-opioid receptor gene. , 1997, Brain research.